Telesis Bio Reports Second Quarter 2023 Financial Results
10 août 2023 16h05 HE
|
Telesis Bio
SAN DIEGO, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today reported financial results for the second...
Global Biopreservation Market to Reach USD 16.61 Billion by 2030, Fueled by Rising Funding Assistance in Healthcare
07 août 2023 04h38 HE
|
Research and Markets
Dublin, Aug. 07, 2023 (GLOBE NEWSWIRE) -- The "Biopreservation Market Size, Share & Trends Analysis Report By Product (Equipment, Media, LIMS), By Application (Regenerative Medicine,...
Synthetic Biology (SynBio) in Drug Discovery and Next-generation Therapeutics Research Report 2023
20 juil. 2023 04h53 HE
|
Research and Markets
Dublin, July 20, 2023 (GLOBE NEWSWIRE) -- The "Synthetic Biology (SynBio) in Drug Discovery and Next-generation Therapeutics" report has been added to ResearchAndMarkets.com's offering. The...
Global Synthetic Biology Market Estimated to Hit $77.5 Billion by 2030: Synergy of AI and Synthetic Biology Creates Lucrative Growth Prospects
10 juil. 2023 07h18 HE
|
Research and Markets
Dublin, July 10, 2023 (GLOBE NEWSWIRE) -- The "Synthetic Biology: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Synthetic...
eureKARE seeks disruptive synthetic biology solutions to tackle environmental and sustainability challenges
03 juil. 2023 08h37 HE
|
EUREKARE
The 2nd edition of the eurekAWARDS is launched! Luxembourg, Belgium, Monaco, and Paris, France – 3 July 2023: eureKARE, a pioneering company focused on financing and building next generation...
Telesis Bio to Present at Jefferies Healthcare Conference 2023
08 juin 2023 09h05 HE
|
Telesis Bio
SAN DIEGO, June 08, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, announced that Todd R. Nelson, Ph.D., CEO and Founder...
Synlogic Reminds Stockholders of 2023 Annual General Meeting Details
08 juin 2023 06h45 HE
|
Synlogic, Inc.
CAMBRIDGE, Mass., June 08, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, today reminded stockholders that it will...
Synlogic Announces Data Presentations at the 2023 Synthetic Biology: Engineering, Evolution & Design (SEED) Conference
24 mai 2023 06h35 HE
|
Synlogic, Inc.
CAMBRIDGE, Mass., May 24, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, today announced its planned presentations at...
Telesis Bio to Present at SynBioBeta 2023
23 mai 2023 09h00 HE
|
Telesis Bio
SAN DIEGO, May 23, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced they will be showcasing their benchtop...
Synlogic to Present at the Jefferies Global Healthcare Conference
23 mai 2023 06h50 HE
|
Synlogic, Inc.
CAMBRIDGE, Mass., May 23, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, today announced that Aoife Brennan, M.B....